Physician profile
John Doyle
NPI 1508974106
$2,113.95
in general payments reported to CMS, 2019-2025
12 companies · $528 in 2025
The $528 reported for 2025 was more than what 91% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $86.13 · 2021: $15.10 · 2022: $248 · 2023: $411 · 2024: $483 · 2025: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,421.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $600.44 | 2019-2024 | |
| Abbott Laboratories | $598.49 | 2020-2025 | Amplatzer Amulet, Diamondback Coronary, Mitraclip |
| Becton, Dickinson and Company | $369.32 | 2024-2025 | Hemosphere |
| Abiomed | $138.04 | 2024 | Impella |
| Bard Peripheral Vascular, INC. | $105.14 | 2024 | Venovo |
| Boston Scientific Corporation | $99.83 | 2025 | Watchman Access System, Watchman |
| Medtronic Vascular, INC. | $62.50 | 2019 | |
| Fisher & Paykel Healthcare INC | $38.54 | 2024 | Fisher & Paykel Healthcare |
| Merck Sharp & Dohme LLC | $36.66 | 2022-2025 | Bridion |
| Elutia, INC. | $33.65 | 2019 | |
| Medtronic, INC. | $16.24 | 2023 | Bis |
| Ge Healthcare | $15.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Doyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.